<?xml version="1.0" encoding="UTF-8"?>
<p id="p0100">In general, human at all ages can easily be infected with COVID-19. Pharmacists should particularly strengthen pharmaceutical care for special population, such as pregnant or lactating women, children, adolescents and elderly patients. For pregnant patients, the physiological factors of pregnancy should be taken into full consideration. It is recommended to use medications with FDA Pregnancy Category B or C, and avoid using medications of D class.
 <xref rid="bib22" ref-type="bibr">
  <sup>22</sup>
 </xref> Regularly monitor vital signs of patients and fetuses during medication use, and adjust medication regimens if necessary. To prevent the spread of the SARS-CoV-2 and prevent drugsâ€™ harm to infants through breast milk, pharmacists should advise lactating patients to suspend breastfeeding.
 <xref rid="bib23" ref-type="bibr">
  <sup>23</sup>
 </xref> As the safety and efficacy of antiviral drugs for children and adolescents remains unclear, medication regimens should be formulated carefully. For critically ill children, drugs for adults could be considered and dosage must be adjusted.
 <xref rid="bib24" ref-type="bibr">
  <sup>24</sup>
 </xref> For elderly patients with impaired immunity or complicated chronic diseases, pharmacists should adjust the dosage according to their liver and kidney function, manage medications for secondary prevention, and pay close attention to drug interactions.
</p>
